No Data
No Data
Jianfeng Group (600668.SH): Net profit of 2,4283 million yuan in the first quarter decreased by 89.51% year-on-year
Gelonghui, April 29丨Jianfeng Group (600668.SH) released its report for the first quarter of 2024, achieving operating income of 602 million yuan, a year-on-year decrease of 0.93%; net profit attributable to shareholders of listed companies was 2,4283 million yuan, a year-on-year decrease of 89.51%; and basic earnings per share were 0.0071 yuan.
Jianfeng Group (600668.SH): Injectable cefmetoxime hydrochloride passed generic drug consistency evaluation
Jianfeng Group (600668.SH) issued an announcement, and the company obtained the “Drug Supplement Application...” for injectable cefmetoxime hydrochloride
Express News | Jianfeng Group: The subsidiary received a notice of approval for a supplementary application for injectable cefmetoxime hydrochloride drugs
Jianfeng Group (600668.SH): Employee Supervisor Pang Xiong passed away
Gelonghui, April 17, 丨 Jianfeng Group (600668.SH) announced that Mr. Pang Xiong, employee supervisor of the 11th Supervisory Board, unfortunately passed away on April 16, 2024 due to ineffective medical treatment. During his tenure at the company, Mr. Pang Xiong worked diligently, performed his duties with due diligence, and faithfully carried out the duties and obligations of supervisors. The company expressed its deep condolences on the death of Mr. Pang Xiong and extended its deepest condolences to his family.
There's No Escaping Zhejiang Jianfeng Group Co., Ltd.'s (SHSE:600668) Muted Earnings
When close to half the companies in China have price-to-earnings ratios (or "P/E's") above 27x, you may consider Zhejiang Jianfeng Group Co., Ltd. (SHSE:600668) as an attractive investment with its 13
Jianfeng Group (600668.SH): Acetaminophen suppositories obtained drug registration certificate
Gelonghui January 19 丨 Jianfeng Group (600668.SH) announced that Zhejiang Erying Pharmaceutical Co., Ltd., a holding subsidiary of the wholly-owned subsidiary Zhejiang Jianfeng Pharmaceutical Co., Ltd., has received the “Drug Registration Certificate” for acetaminophen suppositories approved and issued by the State Drug Administration. Acetaminophen suppositories are antipyretic and analgesic drugs. They are classified as chemical class 3. They are used for fever caused by the common cold or influenza in children, and are also used to relieve mild to moderate pain such as headache, joint pain, migraine, toothache, muscle pain, and neuralgia.
No Data